FDA Registration for Cosmetics: What Beauty Brands Need Under MoCRA
“FDA registration doesn’t validate the formula. It tells FDA who is making the product and what is being marketed. The product still has to be properly formulated, supported, manufactured and labeled.”
One of the most persistent beauty-industry myths is that cosmetics either need to be FDA approved or have almost nothing to do with FDA before launch.
Neither is accurate.
Most conventional cosmetics do not require FDA premarket approval. But the Modernization of Cosmetics Regulation Act of 2022, better known as MoCRA, created mandatory FDA registration and listing requirements for many cosmetic businesses.
The wording is what trips people up.
The manufacturing or processing facility is registered.
The cosmetic product is listed.
And the company whose name appears on the label, called the Responsible Person under MoCRA, generally handles or ensures the product listing.
Those are different regulatory actions. Neither one means FDA has reviewed, approved, certified, or endorsed the cosmetic. FDA explicitly says cosmetic facility registration and product listing are not an approval program and that it does not issue registration or listing certificates for promotional use.
Do Cosmetics Need FDA Approval Before They Are Sold?
For most conventional cosmetics, no.
FDA does not generally approve finished cosmetic products or cosmetic ingredients before they enter the market. Color additives are an important exception because they must be permitted for their intended cosmetic uses, and some require batch certification.
That means a moisturizer, serum, cleanser, body lotion, shampoo, or similar conventional cosmetic usually does not go through an FDA premarket approval process comparable to a new drug.
But no premarket approval does not mean no regulation.
A cosmetic company remains responsible for meeting applicable requirements involving safety, labeling, registration and listing where required, adverse-event reporting, prohibited or restricted ingredients, and other provisions of federal law. MoCRA also requires the Responsible Person to ensure and maintain records supporting adequate substantiation of the product's safety.
This distinction is worth getting right:
FDA approval and FDA cosmetic registration are not the same thing.
What Changed Under MoCRA?
Before MoCRA, FDA operated the Voluntary Cosmetic Registration Program, commonly called VCRP.
That old program is gone.
MoCRA created mandatory requirements for many cosmetic product facilities and Responsible Persons. FDA stopped accepting submissions to the former voluntary registration program in 2023 and launched the current registration and listing framework required by MoCRA.
Under the current system:
Cosmetic manufacturers and processors generally register their facilities with FDA.
Responsible Persons generally list marketed cosmetic products with FDA.
There are exemptions, including certain small-business exemptions and provisions for products or facilities regulated under drug or device requirements.
This is why advice written before MoCRA can now be dangerously incomplete.
A founder may find an older article saying:
“Cosmetic registration with FDA is voluntary.”
That was once largely true under the previous system.
It is no longer a reliable general statement.
Facility Registration and Product Listing Are Two Different Things
This is the most important distinction in the article.
Facility Registration
FDA states that manufacturers and processors subject to MoCRA must register their cosmetic product facilities and renew that registration every two years.
The facility is the physical establishment where the cosmetic product is manufactured or processed.
For many emerging brands, that will be the contract manufacturer's facility, not the founder's office and not necessarily the brand's corporate address.
Cosmetic Product Listing
The Responsible Person must generally list each marketed cosmetic product with FDA and provide updates annually. The listing includes information about the product, including its ingredients.
The product itself isn't being “registered” in the same legal sense as the facility.
It is being listed.
Beauty companies often casually say:
“We registered our products with FDA.”
Everyone may understand what they mean, but technically the distinction matters:
Facilities register. Products are listed.
That language becomes especially useful when you're dividing responsibilities between the brand and contract manufacturer.
Who Is the Responsible Person?
Under MoCRA, the Responsible Person is the manufacturer, packer, or distributor whose name appears on the cosmetic product label under the applicable labeling provisions.
For many independent beauty brands, that may be the brand company appearing on the label as the distributor.
For another product, it may be the manufacturer.
This is not necessarily the same entity as the physical contract manufacturing facility.
That matters because the Responsible Person carries several obligations under MoCRA, including cosmetic product listing and serious adverse-event responsibilities, along with maintaining safety substantiation records.
So when a founder asks:
“Does my manufacturer handle FDA registration?”
the better answer is:
Which FDA obligation are we talking about?
The manufacturer may handle the facility registration.
The brand may still be the Responsible Person responsible for product listing and other obligations.
Your Contract Manufacturer's Registration Does Not Automatically List Your Product
This is one of the most commercially important distinctions for founders.
Suppose your contract manufacturer tells you:
“We're FDA registered.”
That may refer to the manufacturing facility.
It does not automatically mean your finished cosmetic has been properly listed under your brand's Responsible Person obligations.
Likewise, listing a product does not replace facility registration where the manufacturing facility is required to register.
These obligations connect to one another, but one does not substitute for the other.
This is why I would never treat “Is the manufacturer FDA registered?” as the complete regulatory conversation.
You also need to know:
Who is the Responsible Person?
Who is submitting the product listing?
Has the product actually been listed?
Which manufacturing facility number is connected to the listing?
Who will handle annual updates?
That is a much better commercialization checklist.
What Information Is Included in Cosmetic Product Listing?
FDA's current product-listing process requires information including the Responsible Person's name, product name, cosmetic product category, and ingredient information. The listing also connects the product with the facility or facilities where it is manufactured or processed.
FDA's Form 5067 also allows certain additional information to be provided, including items such as a label image and product webpage information.
The important point for a founder is that product listing reaches directly into formulation documentation.
You need to know what product is actually being marketed and what ingredients it contains.
That becomes harder when the formula, supplier information, commercial version, and label are all being managed from different documents.
Product Listing Is Another Reason Formula Version Control Matters
Imagine this development sequence:
Prototype V4 is approved.
The manufacturer substitutes one commercial raw material.
The preservation system is modified during scale-up.
The fragrance is revised.
The ingredient declaration gets updated.
The product launches.
Then somebody pulls the old development formula to complete regulatory information.
Now the regulatory listing may not describe the commercial product accurately.
This isn't really a registration problem.
It's a product-development control problem.
The same final commercial formula should drive:
Manufacturing
Ingredient declaration
Safety substantiation
Product listing
Claims where composition matters
Future reformulation records
Registration and listing become much easier when the technical documentation is organized before commercialization.
Do You Have to Submit Your Exact Formula Percentages to FDA?
FDA requires cosmetic product listings to include ingredient information, but product listing should not be confused with publicly filing the brand's full quantitative formulation as though FDA were reviewing the recipe for approval.
FDA's current listing instructions focus on identifying the product and its ingredients and connecting it to the applicable Responsible Person and manufacturing facilities.
That is different from the quantitative formula a chemist uses to manufacture the product.
This distinction matters because founders occasionally fear that MoCRA product listing effectively publishes their proprietary formula.
That isn't what the registration and listing system is designed to do.
Your quantitative formula remains an important internal technical asset even though FDA receives required product and ingredient information.
What Is an FEI Number?
FDA uses the FDA Establishment Identifier, or FEI, as the required facility registration number for cosmetic facility registration.
FDA advises facility owners or operators to determine whether an FEI already exists before registration and provides an FEI Search Portal for that purpose.
For a brand working with a contract manufacturer, the manufacturer may already have its FEI.
The Responsible Person may need the relevant facility registration information when completing the cosmetic product listing because the product listing connects the marketed cosmetic to the facility where it is manufactured or processed.
An FEI is therefore associated with the facility.
It is not a product approval number.
What Is Cosmetics Direct?
Cosmetics Direct is FDA's electronic system for submitting cosmetic facility registrations and cosmetic product listings.
FDA describes it as a Structured Product Labeling authoring and submission tool designed for cosmetic registration and listing information.
Electronic submission is encouraged, although FDA also provides alternative electronic routes and paper Forms 5066 and 5067.
For most beauty founders, Cosmetics Direct is the name worth remembering.
But again, using Cosmetics Direct does not mean FDA is approving the cosmetic.
It is the submission system for required regulatory information.
Does FDA Charge a Fee for Cosmetic Facility Registration or Product Listing?
FDA's registration and listing guidance states that there is no FDA fee to submit cosmetic facility registration or cosmetic product listing under section 607 of the FD&C Act.
That is useful because founders sometimes encounter third-party companies advertising an “FDA cosmetics registration fee.”
A consultant may legitimately charge for its professional time preparing or managing the filing.
That is different from FDA charging the brand a registration fee.
Be clear about which cost you're paying.
Does FDA Issue a Cosmetic Registration Certificate?
No.
FDA specifically states that cosmetic facility registration and product listing are neither approval programs nor promotional tools, and FDA does not issue certificates for cosmetic facility registrations or product listings.
That means founders should be careful with third-party “FDA certificates” that could make a product appear officially approved or certified by FDA.
A consultant may provide confirmation that a submission was completed.
FDA may provide registration or listing identifiers through the system.
Neither should be converted into:
FDA Certified
FDA Approved
or a badge implying federal endorsement of the cosmetic.
FDA Registration Is Not a Marketing Claim
This is where regulatory compliance sometimes gets turned into branding.
A company completes a required filing and wants to put:
FDA REGISTERED
prominently on its packaging.
That can be misleading because consumers may reasonably interpret the statement as evidence that FDA evaluated or approved the product.
FDA expressly says registration and listing are not promotional programs.
I would treat registration as back-end regulatory infrastructure.
The strongest product claim is still what the product itself can legitimately support.
How Often Does a Cosmetic Facility Have to Renew FDA Registration?
A facility subject to the registration requirement must renew its registration every two years.
FDA's February 2026 update clarified that the renewal date is based on the facility's initial registration date. For example, a facility first registered on February 20, 2024 would have its next renewal due by February 20, 2026.
FDA now provides both:
Biennial renewal with changes
and
Abbreviated renewal when no changes have occurred.
This is another reason registration cannot be treated as a one-time launch task.
It becomes an ongoing compliance responsibility.
How Often Does a Cosmetic Product Listing Need to Be Updated?
The Responsible Person must provide updates to cosmetic product listings annually. FDA's current Form 5067 instructions also provide an abbreviated renewal process when nothing has changed and a mechanism for identifying products that have been discontinued.
So the cadence is different:
Facility registration: every two years
Product listing: annual updates
That distinction is worth putting into the company's compliance calendar.
What Happens When the Formula Changes?
Not every formula modification creates the same regulatory impact.
But the product listing needs to remain current.
If a change affects the information contained in the listing, the Responsible Person needs to evaluate the appropriate update. FDA requires annual updates and provides mechanisms for making changes to existing listings.
From a formulation standpoint, this is where change control becomes important.
A supplier changes the composition of a blend.
An active is removed.
A fragrance changes.
The preservative system is replaced.
The product name changes.
Manufacturing moves.
Any of those may affect more than one commercial record.
A well-run change review considers:
Formula.
Ingredient declaration.
Safety substantiation.
Stability.
Claims.
Product listing.
Packaging.
Manufacturing documentation.
The regulatory filing shouldn't be the first place anyone discovers that the commercial product changed.
What Happens When You Change Contract Manufacturers?
Moving production can affect FDA information even if the formula stays exactly the same.
The product listing identifies the facility or facilities associated with manufacture or processing, so changing manufacturers can require corresponding regulatory updates.
The new facility also needs to have the appropriate registration status unless an exemption applies.
Then there is the technical side.
A formula transferred to a new manufacturer may still require:
Raw-material equivalency review
Scale-up
Process adjustment
Stability confirmation
Packaging evaluation
Specification review
Cosmeta's articles on technology transfer, scale-up, and custom formulation vs. contract manufacturing go deeper into that process.
FDA listing is one administrative piece of a much larger manufacturing transfer.
Formula Ownership Can Make Manufacturer Changes Easier to Manage
FDA does not require a beauty brand to own its formula.
A manufacturer-owned or private-label formula can still be marketed in compliance with applicable registration and listing requirements.
But formula ownership becomes useful when something changes.
With 100% ownership of the finished quantitative formula, a brand has visibility into:
The actual quantitative composition
Ingredient percentages
Commercial raw materials
Hero active levels
Formula revisions
Materials that may need to change during transfer
That gives the brand a stronger technical reference if it needs to move manufacturing, update the product, optimize costs, or adapt to regulatory changes.
Formula ownership does not give the brand ownership of supplier patents, trademarks, proprietary ingredient technologies, or other third-party intellectual property.
It simply gives the brand greater control over its own finished product architecture.
Registration is a regulatory obligation.
Formula ownership is a business-control decision.
The two intersect, but they are not the same thing.
Does a Small Beauty Business Have to Register With FDA?
Possibly not.
MoCRA includes a small-business exemption from certain GMP, facility-registration, and product-listing requirements.
FDA's guidance defines a small business for this purpose generally as a Responsible Person or facility owner/operator whose average gross annual U.S. sales of cosmetic products for the previous three-year period are less than $1 million, adjusted for inflation, provided the business is not involved with certain excluded product categories.
The inflation adjustment matters.
So does the product category.
A founder should not simply say:
“We're under $1 million, so we're exempt.”
There is another test.
Some Products Lose the Small-Business Exemption
The small-business exemption does not apply to businesses involved with certain cosmetic products, regardless of sales.
FDA currently identifies four categories:
Products that regularly contact the mucous membrane of the eye under customary or usual use.
Injected cosmetics.
Cosmetics intended for internal use.
Certain cosmetics intended to alter appearance for more than 24 hours when consumer removal is not part of customary or usual use.
That first and fourth category can matter surprisingly often in beauty.
FDA's guidance says products such as eye shadow, eye makeup remover, certain eyeliners, and false-eyelash adhesive may regularly contact the mucous membrane of the eye. Facial cleansers, moisturizers, and serums generally would not be expected to do so under customary use.
FDA also gives examples of products potentially intended to alter appearance for more than 24 hours, including certain nail polishes, some hair dyes, some eyebrow dyes, tattoo inks, and certain leave-on skin preparations.
So product format matters.
False Eyelash Adhesive Is a Good Example of Why Category Details Matter
Imagine two small beauty brands with similar revenue.
One sells facial moisturizers.
The other sells false-eyelash adhesive.
The first may potentially qualify for the small-business registration and listing exemption if all applicable criteria are satisfied.
The second may not, because FDA's guidance identifies false-eyelash adhesive among the products expected to regularly contact the mucous membrane of the eye.
This is why generic advice like:
“Brands under $1 million don't have to register.”
is incomplete.
The product itself matters.
You Don't Apply to FDA for a Small-Business Exemption Certificate
Another useful detail: FDA's guidance says the agency is not generally asking companies to submit documentation proving that they meet the small-business exemption, and FDA does not provide small-business exemption certificates for cosmetic facilities or Responsible Persons.
The business still needs to understand why it qualifies and maintain appropriate records supporting its own compliance position.
Again, this isn't an FDA certification program.
Exempt Does Not Mean Exempt From Cosmetic Law
This is probably the most important point for small brands.
A small business may qualify for an exemption from facility registration and product listing.
That does not mean:
The formula can be unsafe.
The ingredient list can be wrong.
Claims can be misleading.
Color additives can be used illegally.
Adverse-event responsibilities disappear.
Basic cosmetic law no longer applies.
FDA states clearly that cosmetic products must still be safe for consumers under labeled or customary conditions of use and properly labeled.
An exemption is an exemption from specified requirements.
It isn't a regulatory free pass.
Can an Exempt Small Business Register Voluntarily?
Yes.
FDA currently accepts voluntary registration and product-listing submissions from entities that are not required to register or list because they qualify for an exemption.
Whether doing so creates enough practical value for a particular small brand is a business and regulatory decision.
What it does not create is FDA approval.
Voluntary submission still shouldn't be turned into a government endorsement claim.
What if Your Product Is Both a Cosmetic and a Drug?
This changes the analysis significantly.
Products can be both cosmetics and drugs when they have both cosmetic and drug intended uses.
Examples may include certain:
Sunscreens
Acne products
Antidandruff products
depending on the actual product and claims.
FDA's MoCRA registration guidance states that cosmetics that are also drugs are handled under the applicable drug establishment registration and product-listing framework rather than duplicating the cosmetic product-listing requirements under section 607. Facilities manufacturing or processing cosmetic-drug products are similarly subject to the applicable drug registration framework, subject to the statutory details.
This is why product classification comes before registration.
You first need to know what you are legally selling.
Then you determine which regulatory pathway applies.
A Moisturizer and an Acne Treatment May Look Similar and Have Different FDA Requirements
This is one of the reasons cosmetic regulation confuses first-time founders.
Two 50 mL face products can sit next to each other on a bathroom counter.
One says:
Hydrating facial lotion
The other says:
Acne treatment
They may even share several ingredients.
But intended use affects regulatory classification.
FDA explains that a product's intended use, including claims made on the label, website, and promotional materials, helps determine whether the product is a cosmetic, drug, or both.
Registration cannot be separated from claims.
Neither can formulation.
Changing a Claim Can Change More Than Marketing
A founder may think:
“We're not changing the formula. We're just changing the website.”
Regulatory classification may still change if the new language changes the intended use of the product.
That can affect:
Labeling
Active ingredients
Testing
Manufacturing
Registration and listing pathway
Claims substantiation
This is one reason I would rather define the intended claims before product development gets too far.
A formulation built as a conventional cosmetic and a product intended to function as an OTC drug are different development projects.
Does Handmade or Home-Based Skincare Need FDA Registration?
Possibly.
FDA does not prohibit manufacturing cosmetics in a home simply because it is a home. But the person making the product remains responsible for avoiding adulteration and complying with applicable requirements.
Whether the facility and products are subject to MoCRA registration and listing depends on the applicable business and product circumstances, including whether the small-business exemption applies.
“Handmade” is not itself a federal exemption category.
Neither is:
Indie.
Natural.
Clean.
Etsy.
Small batch.
Founder made.
Regulatory obligations follow the actual business and product, not the brand aesthetic.
What if a U.S. Brand Uses an Overseas Manufacturer?
Foreign cosmetic manufacturing facilities can also fall within MoCRA's registration framework when they manufacture or process cosmetic products for distribution in the United States, subject to applicable exemptions and provisions.
The product listing still needs to connect the marketed product to the relevant manufacturing facility information.
For a U.S. brand outsourcing overseas, this makes regulatory planning part of supplier qualification.
Before commercial production, the brand should understand:
The facility's FDA status
FEI information
Who will maintain facility registration
Who will act as the Responsible Person
Who will submit the product listing
Who will update it
How formula and ingredient information will be shared
That is much more useful than discovering after the first shipment that everyone assumed another party was handling FDA filings.
FDA Registration Is Only One Part of Import Readiness
A foreign manufacturer being appropriately registered does not automatically make every shipment compliant.
The finished cosmetic still needs to meet applicable U.S. requirements involving labeling, safety, ingredient restrictions, product listing, and product classification.
Imported products may also trigger customs and country-of-origin considerations.
This follows the same general principle we see throughout product development:
One compliant component does not make the entire product compliant.
Registration Does Not Prove the Formula Is Safe
This deserves its own section because registration language can create false confidence.
FDA does not evaluate and approve a conventional cosmetic formula simply because the product was listed.
The Responsible Person remains responsible for safety substantiation.
Under MoCRA, companies must ensure and maintain records supporting adequate substantiation of the cosmetic product's safety. FDA describes adequate substantiation as scientifically robust tests, studies, research, analyses, or other evidence sufficient for qualified experts to support a reasonable certainty that the cosmetic is safe.
That can involve different evidence depending on the product.
The registration submission isn't the safety study.
Registration Does Not Replace Stability Testing
A product listing can tell FDA that a moisturizer exists and identify its ingredients.
It cannot tell you whether the emulsion will separate after eight weeks at elevated temperature.
It cannot tell you whether the formula will discolor.
It cannot tell you whether the viscosity will collapse.
It cannot tell you whether the pump will clog.
It cannot establish a defensible shelf life.
Those require product-development and validation work.
Cosmeta's Cosmetic Stability Testing Explained and How Shelf Life Is Actually Determined for Cosmetic Products address those questions separately.
FDA registration is administrative compliance.
Stability is product science.
Registration Does Not Replace Preservative Efficacy Testing
Likewise, listing a water-based cosmetic does not demonstrate that its preservation system is adequate.
Microbial safety is part of cosmetic safety.
FDA notes that cosmetics do not have to be sterile, but microbial contamination can make a cosmetic hazardous or adulterated.
Depending on the formula and product risk, preservation may need to be evaluated through appropriate microbiological work, including preservative efficacy or challenge testing.
A registered unstable or poorly preserved cosmetic is still a poorly developed product.
Registration Does Not Replace Correct Labeling
Product listing also does not mean FDA reviewed and blessed the commercial artwork.
The package still needs to meet applicable labeling requirements.
That includes issues such as:
Product identity
Net contents
Ingredient declaration
Business information
MoCRA adverse-event contact information
Required warnings
Claims
Cosmeta's Cosmetic Labeling Requirements guide goes deeper into that part of commercialization.
Registration and labeling are connected.
Neither substitutes for the other.
Registration Doesn't Make a Bad Claim Legal
Suppose a serum is properly listed with FDA.
The brand then markets it as:
Treats eczema
or
Regrows hair
without following the applicable drug pathway.
The product's listing does not protect that claim.
FDA determines whether a product is a cosmetic, drug, or both partly through intended use.
Registration cannot rescue an incorrectly classified product.
The claim strategy needs to make sense first.
MoCRA Goes Far Beyond Registration and Listing
It is easy for founders to reduce MoCRA to:
“We need an FDA number.”
MoCRA did considerably more.
FDA identifies major provisions involving:
Facility registration
Product listing
Serious adverse-event reporting
Safety substantiation
Records
Mandatory recall authority
Facility registration suspension authority
Future cosmetic GMP regulations
Future fragrance-allergen labeling regulations
Other expanded FDA authorities and requirements
So completing registration and product listing does not mean:
“We're done with MoCRA.”
It means one part of the compliance structure has been addressed.
Serious Adverse Events Are Now a Formal Responsible Person Obligation
Under MoCRA, the Responsible Person must report a serious adverse event associated with use of a cosmetic product in the United States to FDA within 15 business days after receiving the report. Follow-up medical or other information received within one year can trigger additional reporting obligations within 15 business days.
This connects directly back to labeling.
The cosmetic label must provide a domestic address, domestic phone number, or electronic contact information through which the Responsible Person can receive adverse-event reports.
That means post-market safety isn't separate from packaging.
The consumer needs a route to reach the entity responsible for handling the information.
FDA Can Suspend a Cosmetic Facility Registration
Registration also has regulatory consequences beyond data collection.
MoCRA gives FDA authority to suspend a facility's registration under specified serious circumstances, including when the agency determines that a cosmetic manufactured or processed by the facility has a reasonable probability of causing serious adverse health consequences or death and applicable statutory conditions are met.
If the registration is suspended, distributing or selling cosmetic products from that facility in the United States becomes prohibited.
That is a significant expansion from the old perception of cosmetic registration as optional paperwork.
How Many Cosmetic Products Are Now Listed With FDA?
As of June 30, 2026, FDA reported 16,398 active cosmetic facility registrations and 1,298,361 active cosmetic product listings under MoCRA.
That number is useful less as market-size data than as evidence of how established the new system has become.
MoCRA registration and listing are no longer a future regulatory concept.
For applicable businesses, they are part of current U.S. cosmetic commercialization.
Do You Need an FDA Number Before You Develop a Formula?
Usually, formula development itself comes earlier.
You do not need FDA to approve the ingredient architecture before a cosmetic chemist begins developing a conventional cosmetic.
But the regulatory pathway should still inform development.
Before formulation is finalized, the team should know:
Is this a cosmetic?
Could the intended claims make it a drug?
Are any color additives involved?
Is the target product one of the categories affecting small-business exemptions?
Where will it be manufactured?
Who will be the Responsible Person?
Which markets will the product enter?
Those questions may influence formulation, testing, manufacturing, labeling, and commercial timelines.
FDA registration belongs near the end of a longer regulatory-development chain, but regulatory thinking belongs near the beginning.
A Better Pre-Launch Sequence
For a conventional cosmetic, I would think about commercialization in roughly this order:
Define the product and intended claims.
Make sure you understand whether it is actually a cosmetic.
Develop the formula.
Use the intended consumer, market, performance, ingredient constraints, manufacturing, and commercial strategy to drive development.
Establish safety and stability support.
Build the evidence appropriate to the finished product.
Finalize manufacturing and packaging.
Know where and how the commercial product will be made.
Finalize the ingredient declaration and label.
Make sure the artwork reflects the actual commercial formula and Responsible Person structure.
Determine MoCRA registration and listing obligations.
Confirm facility registration status, Responsible Person responsibilities, exemptions where applicable, and product-listing requirements.
Launch with a system for ongoing compliance.
Annual listing updates, biennial facility renewal, complaint handling, adverse-event reporting, formula changes, and label updates need owners.
The precise workflow can overlap.
The important point is that FDA registration isn't the first or last regulatory question.
Who Should Handle FDA Cosmetic Registration and Listing?
That depends on the company structure.
Potentially involved parties include:
Brand
Responsible Person
Contract manufacturer
Regulatory consultant
U.S. agent for a foreign facility
Legal counsel in more complex cases
The key is to assign responsibility rather than assume it.
A contract should make clear who is handling:
Facility registration.
Product listing.
Annual updates.
Formula changes that affect listing.
Discontinuations.
Label updates.
Relevant records.
Adverse-event communication.
A great manufacturer can handle its responsibilities perfectly and still not know that the founder assumed it was doing something that legally belongs to the brand.
Good compliance starts with clear ownership.
Private Label Does Not Remove the Brand's Regulatory Responsibilities
Private label can simplify product development considerably.
The manufacturer may already have:
A developed formula
Manufacturing systems
Ingredient documentation
Stability information
Regulatory experience
Facility registration
That can make commercialization faster.
But the brand still needs to know whose name appears on the label and who is acting as the Responsible Person.
If the brand is the Responsible Person, it cannot simply outsource awareness of its legal obligations because the formula came from a private-label manufacturer.
Private label changes product ownership and development structure.
It does not automatically move every regulatory responsibility to the factory.
Custom Formulation Does Not Make Registration More Difficult
There is also no reason to assume an original custom formula is inherently harder to list with FDA.
A well-documented custom-development process can actually make the regulatory workflow quite clean.
The brand can know:
The exact commercial formula
The ingredient declaration
Raw-material compositions
Manufacturing partner
Product category
Formula history
Which version is being marketed
With 100% ownership of the finished quantitative formula, the brand also retains greater visibility if product or manufacturing changes later.
The regulatory system doesn't prefer private label or custom formulation.
What matters is whether the product is correctly documented and the applicable obligations are being met.
What Formula Ownership Does Not Do
Because formula ownership is strategically valuable, it is equally important not to overstate it.
Owning your formula does not:
Register your facility.
List the product.
Prove safety.
Create compliant labeling.
Give you FDA approval.
Qualify you for a small-business exemption.
Transfer a supplier's patents.
Eliminate the need for manufacturing validation.
It gives the brand control over the quantitative formulation asset.
Regulatory compliance still has its own requirements.
Common FDA Registration Mistakes Beauty Founders Make
Several mistakes tend to come from the same misunderstanding: treating FDA registration as a single badge rather than a system.
“My Manufacturer Is FDA Registered, So We're Done”
Not necessarily.
Confirm the product-listing obligations of the Responsible Person too.
“My Product Is FDA Approved”
Conventional cosmetics generally aren't approved before marketing, and registration or listing does not change that.
“We're Small, So MoCRA Doesn't Apply”
You may qualify for certain exemptions, but size is not the only factor. Certain product categories do not qualify for the small-business registration and listing exemption.
“I Registered Once, So I'm Finished”
Facility registration renews every two years, while product listings require annual updates.
“Registration Means FDA Checked the Formula”
It doesn't.
Safety and compliance remain the company's responsibility.
“The Manufacturer Will Handle Everything”
Maybe.
Maybe not.
Define the division of responsibility before launch.
Why Regulatory Planning Belongs Inside Product Development
This is probably the larger Cosmeta point.
A formulator doesn't need to personally submit every regulatory filing to make regulatory thinking part of formulation.
Suppose the founder wants:
An eye product.
A 48-hour stain.
A sunscreen.
An acne treatment.
A conventional moisturizer.
Those product concepts can lead into different regulatory questions.
If the chemist only learns the intended claims after the formula is approved, the development process is working backward.
The same applies to manufacturing.
If a brand plans to manufacture overseas, enter Europe, pursue Credo, or eventually move manufacturers, those decisions can affect how the product should be documented from the beginning.
Regulatory compliance is much easier when the commercial destination is known while the product is still being built.
FDA Compliance Is a System, Not a Number
This is probably the most useful misconception to remove.
A founder often wants:
The FDA registration number.
But there is no one magic FDA number that makes a cosmetic ready for market.
Depending on the business, you may encounter:
FEI for the manufacturing facility
Facility registration information
Product listing information
Responsible Person obligations
Drug establishment or product information for cosmetic-drug products
Other regulatory identifiers
None of those replace:
Safe formulation.
Accurate labeling.
Appropriate testing.
Claims compliance.
Manufacturing controls.
Post-market safety monitoring.
The paperwork matters.
The product underneath the paperwork still matters more.
Key Takeaways
Most conventional cosmetics do not require FDA premarket approval, but MoCRA now requires many cosmetic manufacturers and processors to register their facilities and many Responsible Persons to list marketed cosmetic products with FDA.
The most important terminology is simple:
Facilities register.
Products are listed.
Facility registrations are generally renewed every two years. Cosmetic product listings are updated annually.
Certain small businesses may qualify for exemptions, generally based on average U.S. cosmetic sales below the statutory $1 million threshold adjusted for inflation, but the exemption does not apply to certain categories including products that regularly contact the eye mucosa and certain long-lasting appearance-altering products.
FDA does not charge a section 607 registration or listing fee and does not issue cosmetic registration or product-listing certificates for promotional use.
Most importantly, registration does not equal approval. It does not prove that the formula is safe, stable, preserved, correctly labeled, or appropriately claimed.
Those remain product-development and compliance responsibilities.
Cosmeta's Perspective
I think MoCRA is forcing beauty founders to see something that was always true:
A cosmetic product is more than a formula.
You can have a beautiful formulation and still have the wrong label.
You can have a compliant label and poor safety documentation.
You can have a registered manufacturer and an unlisted product.
You can list the product correctly and still make a claim that changes its regulatory category.
All of those pieces eventually have to line up.
From the formulation side, the biggest opportunity is simply to build products with enough technical control that compliance doesn't become detective work later.
Know which formula is commercial.
Know what is actually in it.
Know who manufactures it.
Know what you are claiming.
Know who owns the formula.
Know who is the Responsible Person.
Know what changes when you move manufacturers, reformulate, or expand into another market.
That doesn't turn the chemist into the regulatory department.
It creates a much better product-development system.
And for a growing beauty brand, that system becomes more valuable with every product you launch.
Ready for the Next Step
Before launch, separate FDA approval, facility registration, and cosmetic product listing into three different concepts. Then identify which requirements actually apply to the product and business, who owns each responsibility, and whether the final commercial formula, label, manufacturer, and regulatory records all describe the same product.
FAQs
-
Most conventional skincare cosmetics do not require FDA premarket approval. Cosmetics must still be safe and properly labeled, and many companies now have mandatory facility-registration and product-listing obligations under MoCRA. Color additives are an important exception because they must be approved for their intended cosmetic uses. Products that are legally drugs, or both cosmetics and drugs, follow additional regulatory requirements.
-
Under MoCRA, many cosmetic products must be listed with FDA by the Responsible Person, while manufacturers and processors generally register their facilities. Certain exemptions apply, including exemptions for qualifying small businesses, although some product categories are excluded from the small-business exemption.
-
FDA's MoCRA guidance generally defines a qualifying small business as a Responsible Person or facility owner/operator with average gross annual U.S. cosmetic sales for the previous three years below $1 million, adjusted for inflation. The exemption does not apply to certain categories, including cosmetics that regularly contact the mucous membrane of the eye, injected products, products intended for internal use, and certain products intended to alter appearance for more than 24 hours.
-
Not necessarily. Your contract manufacturer's facility registration addresses the manufacturing facility. The Responsible Person must separately ensure that applicable marketed cosmetic products are listed with FDA. If your brand's name appears on the label as the manufacturer, packer, or distributor, your company may be the Responsible Person under MoCRA.
-
Cosmetic facility registration is generally renewed every two years, while the Responsible Person must provide annual updates to cosmetic product listings. FDA introduced updated Cosmetics Direct tools in 2026 to support biennial facility-registration renewals.
